ONWARD Medical NV: ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights

Nature Medicine published Up-LIFT pivotal trial results Submitted FDA De Novo application for ARC-EX® System Successfully raised EUR 20M in equity capital EINDHOVEN, the Netherlands, May 23

Related Keywords

Boston ,Massachusetts ,United States ,Amsterdam ,Noord Holland ,Netherlands ,Switzerland ,Aditi Roy ,Amori Fraser ,Drug Administration ,Neither The Company ,Engineering Center ,Michaelj Fox Foundation For Parkinson Research ,Vp Communications ,Linkedin ,Youtube ,Product Lifecycle Advisory Program ,European Innovation Council ,Nature Medicine ,Dave Marver ,Year To Date Highlights ,Sint Maartenskliniek ,Breakthrough Device Designation ,Total Product Lifecycle Advisory Program ,European Innovation ,Financial Informationpage ,Breakthrough Device Designations ,Euronext Brussels ,Media Inquiries ,Investor Inquiries ,Ihr Portfolio ,